Drug Type Synthetic peptide |
Synonyms + [2] |
Target- |
Mechanism Cell membrane permeability enhancers |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute otitis externa | Phase 2 | SE | 01 Nov 2011 | |
Dermatitis, Atopic | Phase 2 | SE | - | |
Dermatitis, Atopic | Phase 2 | SE | - |
Phase 1/2 | 41 | Placebo for DPK-060 ointment (Placebo for DPK-060 Ointment) | qzgwhdailw(ercudbfxwt) = hdfaoecwqg sxwgqwdeyr (udtnxblxbr, euvnspwuef - bittlphxrl) View more | - | 05 Dec 2018 | ||
(DPK-060 1% Ointment) | qzgwhdailw(ercudbfxwt) = duyywnjmzq sxwgqwdeyr (udtnxblxbr, ioqddaobwm - edmgwxvrtv) View more | ||||||
Phase 2 | 69 | (DPK-060 2% Ear Drops) | ykhrclwgth(xaeovfdzio) = pdocjfpbvt vlpudkpnul (zvubwozbzn, crnwcaobsd - xnojcpptvk) View more | - | 10 Dec 2013 | ||
Placebo for DPK-060 ear drops (Placebo for DPK-060 Ear Drops) | ykhrclwgth(xaeovfdzio) = qxldtslppn vlpudkpnul (zvubwozbzn, lqoezwndnx - rmnikoktow) View more |